Search Results

There are 17695 results for: content related to: IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival

  1. Mutated IDH1 Is a Favorable Prognostic Factor for Type 2 Gliomatosis Cerebri

    Brain Pathology

    Volume 22, Issue 3, May 2012, Pages: 307–317, Mi Jung Kwon, Sung Tae Kim, Mi Jeong Kwon, Doo-Sik Kong, Dageun Lee, Sanghui Park, So Young Kang, Ji-Young Song, Do-Hyun Nam, Yukinari Kato, Yoon-La Choi and Yeon-Lim Suh

    Version of Record online : 14 NOV 2011, DOI: 10.1111/j.1750-3639.2011.00532.x

  2. High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia

    International Journal of Cancer

    Volume 137, Issue 5, 1 September 2015, Pages: 1058–1065, Qiu-Ling Ma, Jing-Han Wang, Yun-Gui Wang, Chao Hu, Qi-Tian Mu, Meng-Xia Yu, Lei Wang, Dong-Mei Wang, Min Yang, Xiu-Feng Yin, Fei-Fei Chen, Sha-Sha Lu, Jian Chen, Zhi-Juan Zhu, Sai-Juan Chen and Jie Jin

    Version of Record online : 13 JAN 2015, DOI: 10.1002/ijc.29395

  3. Isocitrate dehydrogenase 1 and 2 mutations in gliomas

    Journal of Neuroscience Research

    Volume 92, Issue 12, December 2014, Pages: 1611–1620, Magdalena Megova, Jiri Drabek, Vladimira Koudelakova, Radek Trojanec, Ondrej Kalita and Marian Hajduch

    Version of Record online : 31 JUL 2014, DOI: 10.1002/jnr.23456

  4. You have free access to this content
    Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling

    International Journal of Cancer

    Volume 135, Issue 8, 15 October 2014, Pages: 1822–1831, Guido Reifenberger, Ruthild G. Weber, Vera Riehmer, Kerstin Kaulich, Edith Willscher, Henry Wirth, Jens Gietzelt, Bettina Hentschel, Manfred Westphal, Matthias Simon, Gabriele Schackert, Johannes Schramm, Jakob Matschke, Michael C. Sabel, Dorothee Gramatzki, Jörg Felsberg, Christian Hartmann, Joachim P. Steinbach, Uwe Schlegel, Wolfgang Wick, Bernhard Radlwimmer, Torsten Pietsch, Jörg C. Tonn, Andreas von Deimling, Hans Binder, Michael Weller, Markus Loeffler and for the German Glioma Network

    Version of Record online : 28 MAR 2014, DOI: 10.1002/ijc.28836

  5. You have free access to this content
    Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high-dose cytarabine and idarubicin

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2665–2673, Farhad Ravandi, Keyur Patel, Rajyalakshmi Luthra, Stefan Faderl, Marina Konopleva, Tapan Kadia, Mark Brandt, Sherry Pierce, Steven Kornblau, Michael Andreeff, Xuemei Wang, Guillermo Garcia-Manero, Jorge Cortes and Hagop Kantarjian

    Version of Record online : 21 OCT 2011, DOI: 10.1002/cncr.26580

  6. Immunohistochemical profiles of IDH1, MGMT and P53: Practical significance for prognostication of patients with diffuse gliomas

    Neuropathology

    Volume 35, Issue 4, August 2015, Pages: 324–335, Ryosuke Ogura, Yoshihiro Tsukamoto, Manabu Natsumeda, Mizuho Isogawa, Hiroshi Aoki, Tsutomu Kobayashi, Seiichi Yoshida, Kouichiro Okamoto, Hitoshi Takahashi, Yukihiko Fujii and Akiyoshi Kakita

    Version of Record online : 6 MAY 2015, DOI: 10.1111/neup.12196

  7. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

    The Journal of Pathology

    Volume 224, Issue 3, July 2011, Pages: 334–343, M Fernanda Amary, Krisztian Bacsi, Francesca Maggiani, Stephen Damato, Dina Halai, Fitim Berisha, Robin Pollock, Paul O'Donnell, Anita Grigoriadis, Tim Diss, Malihe Eskandarpour, Nadège Presneau, Pancras CW Hogendoorn, Andrew Futreal, Roberto Tirabosco and Adrienne M Flanagan

    Version of Record online : 19 MAY 2011, DOI: 10.1002/path.2913

  8. The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations

    Brain Pathology

    Volume 21, Issue 1, January 2011, Pages: 74–87, Andreas Von Deimling, Andrey Korshunov and Christian Hartmann

    Version of Record online : 3 DEC 2010, DOI: 10.1111/j.1750-3639.2010.00454.x

  9. You have free access to this content
    MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations

    International Journal of Cancer

    Volume 131, Issue 5, 1 September 2012, Pages: 1104–1113, Shani Mulholland, Danita M. Pearson, Rifat A. Hamoudi, Deborah S. Malley, Caroline M. Smith, Jamie M.J. Weaver, David T.W. Jones, Sylvia Kocialkowski, L. Magnus Bäcklund, V. Peter Collins and Koichi Ichimura

    Version of Record online : 11 JAN 2012, DOI: 10.1002/ijc.26499

  10. You have free access to this content
    Molecular signatures classify astrocytic gliomas by IDH1 mutation status

    International Journal of Cancer

    Volume 128, Issue 5, 1 March 2011, Pages: 1095–1103, Grischa Toedt, Sebastian Barbus, Marietta Wolter, Jörg Felsberg, Björn Tews, Frederic Blond, Michael C. Sabel, Stefanie Hofmann, Natalia Becker, Christian Hartmann, Hiroko Ohgaki, Andreas von Deimling, Otmar D. Wiestler, Meinhard Hahn, Peter Lichter, Guido Reifenberger and Bernhard Radlwimmer

    Version of Record online : 12 MAY 2010, DOI: 10.1002/ijc.25448

  11. IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo

    Annals of Neurology

    Volume 69, Issue 3, March 2011, Pages: 455–463, Linda B. C. Bralten, Nanne K. Kloosterhof, Rutger Balvers, Andrea Sacchetti, Lariesa Lapre, Martine Lamfers, Sieger Leenstra, Hugo de Jonge, Johan M. Kros, Erwin E. W. Jansen, Eduard A. Struys, Cornelis Jakobs, Gajja S. Salomons, Sander H. Diks, Maikel Peppelenbosch, Andreas Kremer, Casper C. Hoogenraad, Peter A. E. Sillevis Smitt and Pim J. French

    Version of Record online : 28 MAR 2011, DOI: 10.1002/ana.22390

  12. IDH2 mutation in gliomas including novel mutation

    Neuropathology

    Volume 35, Issue 3, June 2015, Pages: 236–244, Jaemoon Koh, Hwajin Cho, Hannah Kim, Seong Ik Kim, Sumi Yun, Chul-Kee Park, Se-Hoon Lee, Seung Hong Choi and Sung-Hye Park

    Version of Record online : 12 DEC 2014, DOI: 10.1111/neup.12187

  13. You have free access to this content
    Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas

    Cancer

    Volume 119, Issue 4, 15 February 2013, Pages: 806–813, Xiao-Wei Wang, Blandine Boisselier, Marta Rossetto, Yannick Marie, Ahmed Idbaih, Karima Mokhtari, Konstantinos Gousias, Khê Hoang-Xuan, Jean-Yves Delattre, Matthias Simon, Marianne Labussière and Marc Sanson

    Version of Record online : 26 NOV 2012, DOI: 10.1002/cncr.27798

  14. IDH1 Mutations in Oligodendroglial Tumors: Comparative Analysis of Direct Sequencing, Pyrosequencing, Immunohistochemistry, Nested PCR and PNA-Mediated Clamping PCR

    Brain Pathology

    Volume 23, Issue 3, May 2013, Pages: 285–293, Dakeun Lee, Yeon-Lim Suh, So Young Kang, Tae-In Park, Ji Yun Jeong and Se-Hoon Kim

    Version of Record online : 8 NOV 2012, DOI: 10.1111/bpa.12000

  15. Isocitrate Dehydrogenase 1 Analysis Differentiates Gangliogliomas from Infiltrative Gliomas

    Brain Pathology

    Volume 21, Issue 5, September 2011, Pages: 564–574, Craig Horbinski, Julia Kofler, Gabrielle Yeaney, Sandra Camelo-Piragua, Sriram Venneti, David N. Louis, Arie Perry, Geoffrey Murdoch and Marina Nikiforova

    Version of Record online : 14 MAR 2011, DOI: 10.1111/j.1750-3639.2011.00480.x

  16. IDH1 mutation, a genetic alteration associated with adult gliomatosis cerebri

    Neuropathology

    Volume 32, Issue 1, February 2012, Pages: 30–37, Deepti Narasimhaiah, Catherine Miquel, Elisabeth Verhamme, Paul Desclée, Guy Cosnard and Catherine Godfraind

    Version of Record online : 11 APR 2011, DOI: 10.1111/j.1440-1789.2011.01216.x

  17. Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML

    American Journal of Hematology

    Volume 90, Issue 8, August 2015, Pages: 732–736, Courtney D. DiNardo, Farhad Ravandi, Sam Agresta, Marina Konopleva, Koichi Takahashi, Tapan Kadia, Mark Routbort, Keyur P. Patel, Mark Brandt, Sherry Pierce, Guillermo Garcia-Manero, Jorge Cortes and Hagop Kantarjian

    Version of Record online : 21 JUL 2015, DOI: 10.1002/ajh.24072

  18. Unraveling the Glioma Epigenome—From Molecular Mechanisms to Novel Biomarkers and Therapeutic Targets

    Brain Pathology

    Volume 21, Issue 6, November 2011, Pages: 619–632, Bastian Malzkorn, Marietta Wolter, Markus J. Riemenschneider and Guido Reifenberger

    Version of Record online : 13 OCT 2011, DOI: 10.1111/j.1750-3639.2011.00536.x

  19. IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia and associated with NPM1 mutations and FAB-M2 subtype

    International Journal of Laboratory Hematology

    Volume 34, Issue 5, October 2012, Pages: 502–509, H.-Y. CHAO, Z.-X. JIA, T. CHEN, X.-Z. LU, L. CEN, R. XIAO, N.-K. JIANG, J.-H. YING, M. ZHOU and R. ZHANG

    Version of Record online : 11 APR 2012, DOI: 10.1111/j.1751-553X.2012.01422.x

  20. You have full text access to this Open Access content
    Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients

    Cancer Science

    Volume 103, Issue 3, March 2012, Pages: 587–592, Akitake Mukasa, Shunsaku Takayanagi, Kuniaki Saito, Junji Shibahara, Yusuke Tabei, Kazuhide Furuya, Takafumi Ide, Yoshitaka Narita, Ryo Nishikawa, Keisuke Ueki and Nobuhito Saito

    Version of Record online : 13 JAN 2012, DOI: 10.1111/j.1349-7006.2011.02175.x